SuperworthMaze Therapeutics market cap MAZE
Share price times shares outstanding: what the whole company sells for, since 2025.
- Today, Oct 23, 2026
- $1.7B
- Highest close in our data
- $2.4B
- Mar 2026
Maze Therapeutics is worth $1.7B at the close on Oct 23, 2026, at $31.01 a share.
That is up 29% over the last year.
Its highest close in our data was $2.4B in Mar 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.7B | $1.2B | $2.4B | −15% |
| 2025 | $2B | $405.1M | $2B | n/a |
Against its peers
Companies in Biotechnology nearest Maze Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| MAZEMaze Therapeutics | $1.7B |
| VCELVericel | $2.2B |
| ADMAAdma Biologics | $2.4B |
| MGTXMeiraGTx | $884.6M |
| KRYSKrystal Biotech | $9.2B |
| RGENRepligen | $10B |
| TECHBIO-TECHNE | $11.4B |
| HALOHalozyme Therapeutics | $14.3B |
| PLXProtalix BioTherapeutics | $205.5M |
| NBIXNeurocrine Biosciences | $14.5B |
| EXELExelixis | $16B |
| Peer median | $9.6B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Maze Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.